| Primary information |
|---|
| sequence ID | Seq_303 |
| Peptide sequence | AFLEVNEEGSEAAASTAVVIAGR |
| CancerPDF_ID | CancerPDF_ID1935, CancerPDF_ID3082, |
| PMID | 21136997,21136997 |
| Protein Name | Antithrombin-III,Antithrombin-III |
| UniprotKB Entry Name | ANT3_HUMAN,ANT3_HUMAN |
| Fluid | Serum,Plasma |
| M/Z | 2290.1441,2290.1441 |
| Charge | 1,1 |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS |
| Quantification Technique | LC-ESI-MS,LC-ESI-MS |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,NA |
| CancerPDF_ID | CancerPDF_ID1935, CancerPDF_ID3082, |
| p-Value | NA,NA |
| Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
| Length | 23,23 |
| Cancer Type | Colorectal cancer,Normal |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,27 healthy individuals |
| Regulation | NA,NA |
| Validation | Leave One out Cross validation,Leave One out Cross validation |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |